First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nora Ku, MD
TORL Biotherapeutics, LLC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Vincent'S Hospital, the Catholic University of Korea
Suwon, Gyeonggi-do, South Korea
Byoung Yong Shim, MDRecruiting - Asan Medical Center
Seoul, South Korea
Shinkyo Yoon, MDRecruiting - Samsung Medical Center
Seoul, South Korea
Jinseok Ahn, MDRecruiting - Seoul National University Hospital
Seoul, South Korea
Bhumsuk Keam, MDRecruiting - Severance Hospital
Seoul, South Korea
Gun Min Kim, MDRecruiting
- Providence Medical Foundation
Fullerton, California, United States
Recruiting - Ucla - Jccc Clinical Research Unit
Los Angeles, California, United States
Gottfired Konecny, MDRecruiting - University of Kentucky Medical Center
Lexington, Kentucky, United States
Recruiting - University of Minnesota
Minneapolis, Minnesota, United States
Boris Winterhoff, MD, PhDRecruiting - Mayo Clinic in Rochester
Rochester, Minnesota, United States
Andrea Wahner Hendrickson, MDRecruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - Cleveland Clinic
Cleveland, Ohio, United States
Recruiting - Sarah Cannon Research Institute Texas Oncology
Tyler, Texas, United States
Heather Pulaski, MDRecruiting - Virginia Cancer Specialists
Fairfax, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Nov 2021
- Primary completion
- 31 Aug 2026
- Completion
- 15 Nov 2026
- Last update posted
- 13 Feb 2026
- Registered enrollment
- 90
- Registry id
- NCT05103683
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.